Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01915810 · ClinicalTrials.gov registry record · NA

Physical Activity in Promoting Smoking Cessation in African Americans

A NA study of Healthy Subject and Current Smoker, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT01915810: Active NA study of Healthy Subject and Current Smoker, sponsored by M.D. Anderson Cancer Center.

NCT01915810 is a NA study of Healthy Subject and Current Smoker that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 45 participants, below the 245-participant average among 16 other Healthy Subject trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01915810, a NA study of Healthy Subject and Current Smoker, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

This randomized pilot clinical trial studies the use of physical activity in promoting the discontinuation of the habit of smoking (smoking cessation) in African Americans. Participating in physical activity during an actual smoking quit attempt may work better in helping African Americans stop smoking.

Interventions

  • OTHER Laboratory Biomarker Analysis
  • OTHER Questionnaire Administration
  • BEHAVIORAL Exercise Intervention
  • OTHER Tobacco Cessation Counseling
  • DRUG Nicotine Patch

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2014-01-29
Est. Completion 2027-01-31
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the registry record for NCT01915810 still lists

NCT01915810 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 245-participant average among 16 other Healthy Subject trials with a reported enrollment target (82% lower).

The record links to 2 conditions, with Healthy Subject appearing as the primary indexed condition, and to 5 interventions - of which Laboratory Biomarker Analysis is the first listed.

NCT01915810 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT01915810 about?

NCT01915810 is a clinical study titled "Physical Activity in Promoting Smoking Cessation in African Americans". This randomized pilot clinical trial studies the use of physical activity in promoting the discontinuation of the habit of smoking (smoking cessation) in African Americans. Participating in physical activity during an actual smoking quit attempt may work better in helping African Americans stop smok...

What is the current status of trial NCT01915810?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2014-01-29. Estimated completion is 2027-01-31.

What conditions does trial NCT01915810 study?

This clinical trial studies the following conditions: Healthy Subject, Current Smoker.

What interventions are being tested in trial NCT01915810?

The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER), Exercise Intervention (BEHAVIORAL), Tobacco Cessation Counseling (OTHER), Nicotine Patch (DRUG).

Who is sponsoring clinical trial NCT01915810?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01915810 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Subject

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01915810's enrollment target sits among peer trials

45 12th of 16 higher than 5 of 16 other Healthy Subject trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Subject trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01915810, the US trial registry maintained by the National Library of Medicine. NCT01915810 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.